DRUG · Mapped RxNorm record
Riluzole
Normalized identity: riluzoleView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Efficacy and Tolerability of Riluzole in Treatment Resistant Depression
NCT01204918
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEfficacy and Tolerability of Riluzole in Treatment Resistant Depression
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Depressionverified · MONDO: depressive disorder
Interventions
RiluzoleDRUG · verified · RxNorm: riluzole
placeboDRUG
Sponsors & collaborators
Yale Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01204918 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.